Noninvasive diagnostic tools used to assess the risk of HCA include measurement of maternal serum CRP levels and leukocyte counts, but these conventional infection markers, when used alone, have poor diagnostic value in distinguishing patients with HCA from those with no placental inflammation. Here, CRP is linked to hepatocellular adenoma.